Company: GANX
Filing Date: 2025-06-24
Form Type: 8-K
Source: 0001104659-25-062162
Chunk: 0

Company: Gain Therapeutics, Inc.
Filing Date: 2025-06-24
Form: 8-K
Item: Item 9.01
Chunk 0
---
Item 9.01 Financial Statements and Exhibits

(d) Exhibits

  3.1      Certificate                                                                                                                         
           of Amendment of Amended and Restated Certificate of Incorporation of Gain Therapeutics, Inc., filed with the Secretary of State of  
           the State of Delaware on June 24, 2025.                                                                                             
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  104      Cover Page Interactive Data File (embedded within Inline XBRL document).                                                            

SIGNATURE

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

                           GAIN THERAPEUTICS, INC.                               
  Date: June 24, 2025      By:                          /s/ Gene Mack            
                           Name:                        Gene Mack                
                           Title:                       Chief Executive Officer